These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 2732943
21. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys. Goulet M, Morissette M, Grondin R, Falardeau P, Bédard PJ, Rostène W, Di Paolo T. Synapse; 1999 Jun 01; 32(3):153-64. PubMed ID: 10340626 [Abstract] [Full Text] [Related]
22. Increase in dopamine metabolites in rat brain by neurotensin. Widerlöv E, Kilts CD, Mailman RB, Nemeroff CB, Mc Cown TJ, Prange AJ, Breese GR. J Pharmacol Exp Ther; 1982 Oct 01; 223(1):1-6. PubMed ID: 6811728 [Abstract] [Full Text] [Related]
23. The neurotensin analog NT69L enhances medial prefrontal cortical dopamine and acetylcholine efflux: potentiation of risperidone-, but not haloperidol-, induced dopamine efflux. Prus AJ, Huang M, Li Z, Dai J, Meltzer HY. Brain Res; 2007 Dec 12; 1184():354-64. PubMed ID: 17988654 [Abstract] [Full Text] [Related]
24. Rapid desensitization of dopamine release induced by neurotensin and neurotensin fragments. Faggin BM, Cubeddu LX. J Pharmacol Exp Ther; 1990 May 12; 253(2):812-8. PubMed ID: 2338657 [Abstract] [Full Text] [Related]
25. Mesolimbic dopamine and cortico-accumbens glutamate afferents as major targets for the regulation of the ventral striato-pallidal GABA pathways by neurotensin peptides. Ferraro L, Tomasini MC, Fuxe K, Agnati LF, Mazza R, Tanganelli S, Antonelli T. Brain Res Rev; 2007 Aug 12; 55(1):144-54. PubMed ID: 17448541 [Abstract] [Full Text] [Related]
26. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores. Parker EM, Cubeddu LX. J Pharmacol Exp Ther; 1986 Apr 12; 237(1):179-92. PubMed ID: 3007736 [Abstract] [Full Text] [Related]
27. Compensatory increase in extracellular dopamine in the nucleus accumbens of adult rats with neonatal 6-hydroxydopamine treatment. Ikegami M, Ichitani Y, Takahashi T, Iwasaki T. Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Jun 12; 26(3):111-7. PubMed ID: 16866211 [Abstract] [Full Text] [Related]
28. Regulation of dopamine synthesis in the medial prefrontal cortex: studies in brain slices. Wolf ME, Galloway MP, Roth RH. J Pharmacol Exp Ther; 1986 Mar 12; 236(3):699-707. PubMed ID: 2869140 [Abstract] [Full Text] [Related]
31. Modification of inherent and drug-induced dopaminergic activity after exposure to benzo(alpha)pyrene. Konstandi M, Harkitis P, Thermos K, Ogren SO, Johnson EO, Tzimas P, Marselos M. Neurotoxicology; 2007 Jul 12; 28(4):860-7. PubMed ID: 17570529 [Abstract] [Full Text] [Related]
38. Effects of CI-943, a potential antipsychotic drug, and haloperidol on regional brain neurotensin concentrations. Levant B, Bissette G, Davis MD, Heffner TG, Nemeroff CB. Synapse; 1991 Nov 12; 9(3):225-30. PubMed ID: 1685600 [Abstract] [Full Text] [Related]
39. Early changes in neuropeptide mRNA expression in the striatum following reserpine treatment. Harrison MB, Kumar S, Hubbard CA, Trugman JM. Exp Neurol; 2001 Feb 12; 167(2):321-8. PubMed ID: 11161620 [Abstract] [Full Text] [Related]
40. Increase of dopamine synthesis in synaptosomes from rats treated with neuroleptics or reserpine. Tissari AH. Med Biol; 1982 Feb 12; 60(1):38-41. PubMed ID: 6121960 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]